(Q38823554)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Immunogenicity of somatic mutations in human gastrointestinal cancers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Yong-Chen Lu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

13

Steven A Rosenberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Eric Tran

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Mojgan Ahmadzadeh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Simon Turcotte

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Paul F Robbins

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Jared J Gartner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Zhili Zheng

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Yong F Li

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Satyajit Ray

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

John R Wunderlich

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Robert P Somerville

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

language of work or name

English

0 references

publication date

29 October 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

350

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

1387-1390

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

6266

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

Adoptive cell transfer as personalized immunotherapy for human cancer

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Mutated PPP1R3B is recognized by T cells used to treat a melanoma patient who experienced a durable complete tumor regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Genetic basis for clinical response to CTLA-4 blockade in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Mutational heterogeneity in cancer and the search for new cancer-associated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

21 January 2018

Cancer genome landscapes

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

API5 confers tumoral immune escape through FGF2-dependent cell survival pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Ras history: The saga continues

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

A ras-mutated peptide targeted by CTL infiltrating a human melanoma lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

CD4(+) T-cell recognition of mutated B-RAF in melanoma patients harboring the V599E mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

KRAS: feeding pancreatic cancer proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

NetMHCpan, a method for MHC class I binding prediction beyond humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Inference of high resolution HLA types using genome-wide RNA or DNA sequencing reads

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAD1253

Nivolumab plus ipilimumab in advanced melanoma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26516200

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26516200

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1126/SCIENCE.AAD1253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26516200%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

0 references

1 reference